NadirAlphaNA EN · DE · ES · FR · HI · 中文 · عربي · PL
Advertisement

Jenoptik AG JEN.DE

IR documents · Reporting currency EUR · Quarterly reporting · Figures as of 2026-Q2 · updated 2026-09-28 · ISIN DE000A2NB601

Quarterly and annual results for Jenoptik stock (JEN.DE) since 2023: revenue, earnings, balance sheet, cash flow and management guidance from IR documents, every figure with its source. As of 08/2026, quarterly reporting. Latest reported (Q2 2026): Order backlog, EBITDA margin, Equity ratio. Latest reading: Margin expanding, Order intake, Guidance raised, Acquisition.

Margin expanding Order intake Guidance raised strategy: Acquisition

Published by Michael Wirl · About us · Methodology

The new quarter, monitored by AI. · We follow every stock through its original filings: the latest figures against their history, guidance against actuals; neutral, continuously updated, every figure clickable with its source.
AI-generated report · not investment advice · figures extracted automatically; please verify against the linked original more
AI-generatedCreated with AI assistance from the company's linked original filings (transparency per Art. 50 EU AI Act). More about the tool: Claude Code.
Not investment adviceNeutral financial information, no recommendation, no investment research within the meaning of MiFID II.
Verify yourselfFigures are extracted automatically, errors are possible. Every figure is clickable with its source; the issuer's original documents are always authoritative.
EditorialThe texts (business model, current status, development and others) are written AI-editorially from the original reports alone, cross-checked automatically and backed with sources; the company's own account, no assessment of our own. Methodology
AI research · This page works as a source-backed data basis for further research with AI assistants such as Claude; every figure remains verifiable via the source links.
Advertisement

Business Model#

What the company does and how it earns its money; written AI-editorially, exclusively from the company's original reports, without any assessment of our own.

Jenoptik is a photonics-based technology group headquartered in Jena, Germany, that develops and manufactures high-precision optical systems, sensors, laser modules, and related equipment for industrial and scientific customers. The group generates revenue across four reporting segments: Semiconductor & Advanced Manufacturing, supplying optical and inspection equipment for chip production; Biophotonics, serving medical technology, life science, and defense customers with photonic components and systems; Metrology & Production Solutions, providing measurement and quality-assurance systems predominantly for the automotive and other manufacturing industries; and Smart Mobility Solutions, delivering intelligent traffic management and mobility systems. Revenue depends substantially on capital expenditure cycles in the semiconductor and automotive industries, and the customer base is concentrated among larger industrial enterprises and original equipment manufacturers.

Advertisement

Current Status#

Summary of the most recent reporting period: core figures, drivers and management statements; written editorially from the current original report, every figure backed by a source number.

Jenoptik reported revenue of 262 million euros in the second quarter of 2026, with EBITDA rising 25.5% to 98.9 million euros 28. Order intake increased 53.0% to 723.4 million euros, driven by strong demand in semiconductor equipment, and the order backlog reached 824.8 million euros at a book-to-bill ratio of 1.44 28. The Executive Board raised its full-year guidance, now expecting revenue in the upper half of its previously communicated growth range and an EBITDA margin between 20.0% and 21.0% 28. The acquisition of UAB Fima ITS, now operating as UAB JENOPTIK Baltic, was completed on March 2, 2026, expanding the group's intelligent transportation systems capabilities 28.
Management commentary on the 2026-Q1 results (IR-Quarter):
„Taking into account the persistently high level of market uncertainty, the Executive Board confirms the guidance issued in March for 2026 and expects revenue growth in the single-digit percentage range (2025: 1,046.0 million euros) and an EBITDA margin of 19.0 to 21.0 percent (2025: 18.4 percent).“ – Executive Board 29
Revenue · 2026-Q2262€m+2.8 % vs. 2025-Q2
Net profit · 2026-Q223€m+42.2 % vs. 2025-Q2
EPS · 2026-Q20.40€+53.8 % vs. 2025-Q2
Revenue trend
Guidance
For FY2026, the company guides Revenue to upper half of single-digit percentage range (raised); EBITDA margin to between 20.0 and 21.0 percent (raised); CapEx to slightly below prior-year level of 77.4 million euros (confirmed). 28.
Profitability
Operating income in 2026-Q2 was 36 million euros and net income was 22.9 million euros, with diluted earnings per share of 0.40 euros 128. Operating cash flow was 34.7 million euros, capital expenditure was 9.6 million euros, and free cash flow was 25.1 million euros 128. The EBITDA margin for the quarter was 19.7%, compared to 15.8% in the prior-year period 28.
Leverage
Net debt decreased to 307.5 million euros from 317.4 million euros at year-end 2025, despite dividend payments made during the quarter 28. Cash and cash equivalents were 126.4 million euros at the end of the quarter 128. In April 2026, Jenoptik issued new debenture bonds totaling 150 million euros with maturities evenly distributed across four-, six-, and eight-year tranches 28.
Management view
The Executive Board raised full-year guidance to the upper half of its previously communicated single-digit percentage revenue growth range, with an EBITDA margin target of 20.0% to 21.0% 28. Semiconductor & Advanced Manufacturing segment revenue increased 10.2% to 230.4 million euros, benefiting from strong lithography and inspection business, while Smart Mobility Solutions segment revenue increased 10.7% to 68.3 million euros driven by regional business strength 28. The order backlog grew 39.6% to 824.8 million euros and inventory was built up to 280.6 million euros in anticipation of continued demand growth 28.
Change
Biophotonics segment revenue declined 4.5% to 113.9 million euros as medical technology revenue did not reach prior-year levels, although the defense portion of the segment improved 28. Metrology & Production Solutions segment revenue decreased 13.4% to 79.7 million euros, reflecting a challenging environment in the automotive industry 28.
Risks (current)
Escalating geopolitical tensions involving China, the US, and Taiwan represent a material risk for the Semiconductor & Advanced Manufacturing segment, and excess capacity at chip manufacturers could result in order delays for Jenoptik as a supplier 27 28. The company's focus on larger customers in process automation creates concentration risk if those customers underperform or are lost, and delivery delays to customers in Jordan and Kuwait due to military conflict have been noted, with the volume impact currently described as non-material 27 29. Contingent liabilities of 10,034 thousand euros from an external performance guarantee for a VINCORION customer are outstanding, and the company is involved in a small number of court or arbitration proceedings with provisions recognized 19.
New this reporting period
The acquisition of UAB Fima ITS, now renamed UAB JENOPTIK Baltic, was completed on March 2, 2026, adding intelligent transportation systems capabilities to the group 28. In April 2026, Jenoptik placed new debenture bonds totaling 150 million euros, with maturities evenly distributed across four-, six-, and eight-year tranches 28.
Advertisement

Price & Chart#

Interactive price chart (TradingView) and the trend of key figures from the core tables. The price chart loads only after a click; at that point a connection to TradingView is established.

Daily candles with news and earnings markers. Loads only on click.

Advertisement · affiliate links; we may earn a commissionAffiliate partnerships help us keep these reports free and regularly updated.
Advertisement

Share-Price Drivers#

Factors the company itself names as material for its business development (IR-based); reproduced neutrally, no price forecast and no assessment of our own.

Semiconductor & Advanced Manufacturing capacity build-out and demand
It is the largest and most profitable segment (revenue 108.2, margin 30.6, growth +7.2% in 2026-Q1) and underpins group operating income of 36 in 2026-Q2 29 128
Semiconductor & Advanced Manufacturing segment
Largest segment with revenue 108.2 and a 30.6 margin, growth +7.2%; capacity added via the Dresden micro-optics/high-tech fab launched in 2025 and planned semiconductor-optics expansion at Jena 29 27 22
Smart Mobility Solutions traction
Revenue 31.8 with growth +10.9%; traffic-enforcement systems deployed in Jordan and UAB Fima ITS (now JENOPTIK Baltic) acquired in 2026-03 29 27 28
Biophotonics demand
Segment revenue 56.8 with growth of -10.9%, though margin held at 21.9 29
Metrology & Production Solutions
Revenue 39.1 with growth -3.7% and a margin of -0.4, the weakest of the four units 29
Group profitability and guidance
Operating income of 36 on revenue of 262 in 2026-Q2, up from 22.7 a year earlier, with guidance raised 128 29
New product introductions in Advanced Photonics
Recent launches include the F-Theta lens for additive manufacturing, the MS-I² multispectral imaging solution and the MBSS modular beam-splitting system in 2025 22 27

Sector trend: Photonics demand is diverging: semiconductor-optics and smart-mobility demand is rising with high or improving margins, while life-science (Biophotonics) and metrology demand is softer. Group margins and utilisation are trending higher, supported by raised guidance 29 128

Advertisement

Event Timeline#

This timeline collects the material events from the original reports: guidance changes, revenue and margin signals, strategy shifts, product and M&A announcements. Events are grouped by quarter (most recent first); the grey tag before each event names the event type, the date is the publication date of the source. Management quotes open the quarter block as direct quotes. Per quarter we show the three most defining events; more can be expanded per quarter, older years are collapsed. Every event carries its source as a superscript, clickable number.

Overview: one dot per event · click jumps to the period
earningsrevenuemarginguidancestrategyfinancials2023-Q12023-Q22023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2
2026 · 7 events

2026-Q2 · Apr – Jun 2026

Margin expanding 2026-08-11
EBITDA rose 25.5% to 98.9 million euros with EBITDA margin expanding to 19.7% from 15.8% in the prior-year period 28
Guidance raised 2026-08-11
Executive Board raises full-year guidance to revenue in upper half of single-digit percentage range and EBITDA margin of 20.0-21.0% 28
Acquisition 2026-08-11
Acquisition of UAB Fima ITS (now UAB JENOPTIK Baltic) completed March 2, 2026, adding intelligent transportation systems business 28
Order intake 2026-08-11
Order intake / order book: order backlog EUR 824.8m 28

2026-Q1 · Jan – Mar 2026

„Taking into account the persistently high level of market uncertainty, the Executive Board confirms the guidance issued in March for 2026 and expects revenue growth in the single-digit percentage range (2025: 1,046.0 million euros) and an EBITDA margin of 19.0 to 21.0 percent (2025: 18.4 percent).“ – Executive Board 29
revenue 2026-05-11
Order intake increased 74.4% to 356.9 million euros, including a major order in Semiconductor & Advanced Manufacturing; backlog rose 21.7% to 719.2 million euros with book-to-bill of 1.48 29
Margin expanding 2026-05-11
EBITDA rose 22.5% to 44.4 million euros with margin improving to 18.4%, driven by higher capacity utilization and favorable product mix in semiconductors 29
Guidance confirmed 2026-05-11
Executive Board confirms full-year guidance for single-digit revenue growth and EBITDA margin of 19.0-21.0% 29
2025 · 12 events

2025-Q4 · Oct – Dec 2025

„We are convinced that our key customers and, as their supplier and partner, Jenoptik as well, will benefit significantly from the megatrends of digitization, health, mobility, and sustainability.“ – Dr. Prisca Havranek-Kosicek, Chief Financial Officer 27
Revenue decelerating 2026-03-18
Full-year revenue declined 6.3% to 1,046 million euros due to lower demand in the semiconductor lithography supply chain and challenging automotive market; Biophotonics grew 10.4% and Smart Mobility Solutions grew 8.5% 27
Guidance initiated 2026-03-18
Executive Board expects revenue growth in single-digit percentage range for 2026 with EBITDA margin between 19.0 and 21.0 percent 27
Strategic pivot 2026-03-18
Dr. Stefan Traeger announced resignation from Executive Board effective February 15, 2026 after nine years as Chairman; Daniela Mattheus elected Chairwoman of Supervisory Board effective December 30, 2025 27

2025-Q3 · Jul – Sep 2025

Revenue decelerating 2025-11-12
Nine-month revenue declined 7.6% to 753.2 million euros, with Semiconductor & Advanced Manufacturing down 15.2% and Metrology & Production Solutions down 11.3%; order intake nearly flat with book-to-bill improving to 1.03 26
Margin compressing 2025-11-12
Nine-month EBITDA margin compressed to 17.5% from 19.7% in the prior-year period, impacted by lower utilization and product mix changes in Semiconductor & Advanced Manufacturing 26
Guidance confirmed 2025-11-11
Executive Board expects revenue and EBITDA margin at lower end of guidance ranges for 2025 due to persistent market uncertainty and ongoing cost reduction measures 18

2025-Q2 · Apr – Jun 2025

Revenue decelerating 2025-08-12
H1 order intake fell 9.9% to 472.7 million euros; SBU Semiconductor & Advanced Manufacturing revenue declined 15.1% due to supply chain fluctuations and reduced lithography area revenue 16
Guidance cut 2025-08-12
Executive Board revised 2025 guidance to lower half of minus 5 to plus 5 percent revenue range and EBITDA margin to lower half of 18.0 to 21.0 percent range 16
Divestiture 2025-08-12
Prodomax divestment postponed; sale no longer feasible by end of 2025 due to ongoing challenges in North American automotive sector 16

2025-Q1 · Jan – Mar 2025

Margin compressing 2025-05-12
EBITDA margin compressed to 14.9% from 17.4% in Q1 2024, driven by lower utilization and product mix changes in Semiconductor & Advanced Manufacturing 17
Strategic pivot 2025-05-12
Group reorganized into four Strategic Business Units effective January 1, 2025, replacing prior matrix organization 17
Revenue decelerating 2025-03-31
Revenue declined to 243.6 million euros in Q1 2025 and order intake fell 15.5% to 204.6 million euros, driven primarily by lower demand in the semiconductor equipment sector 25
2024 · 13 events

2024-Q4 · Oct – Dec 2024

„We are convinced that Jenoptik is on the right track with its focus on selected growth areas.“ – Stefan Traeger, Chairman of the Executive Board 15
revenue 2025-03-25
FY2024 revenue grew 4.7% to 1,115.8 million euros, driven by semiconductor equipment business in Advanced Photonic Solutions 14
Margin expanding 2025-03-19
FY2024 EBITDA margin reached 19.9%, at the upper end of the guidance range of 19.5 to 20.0 percent 15
Strategic pivot 2025-03-19
Advanced Photonic Solutions reorganized effective January 1, 2025 into four segments: Semiconductor & Advanced Manufacturing, Biophotonics, Metrology & Production Solutions, and Smart Mobility Solutions, to increase customer focus and efficiency 12

2024-Q3 · Jul – Sep 2024

Margin expanding 2024-11-11
Nine-month EBITDA rose 12.2% to 160.6 million euros with EBITDA margin improving to 19.7% from 18.6% in the prior year 11
Guidance confirmed 2024-11-11
FY2024 revenue and earnings guidance confirmed: mid-single-digit growth and EBITDA margin of 19.5 to 20.0 percent 11
Guidance cut 2024-11-11
FY2025 financial targets postponed to FY2026: revenue of around 1.2 billion euros and EBITDA margin of 21 to 22 percent, due to challenging market environment 11

2024-Q2 · Apr – Jun 2024

Cash flow inflection 2025-08-13
Operating cash flow reached 35.1 EURm vs 6.2 EURm in 2023-Q2 (×5.7). 24
Margin expanding 2024-08-08
H1 2024 EBITDA improved 10.7% to 101.4 million euros with margin reaching 18.8% 9
Guidance confirmed 2024-08-08
FY2024 guidance confirmed: mid-single-digit revenue growth and EBITDA margin of 19.5 to 20.0 percent 9

2024-Q1 · Jan – Mar 2024

Revenue accelerating ◦ 2024-05-07
Revenue increased 9.4% to 256.1 million euros, driven by Advanced Photonic Solutions, particularly Semiconductor Equipment 10
Margin expanding 2024-05-07
EBITDA margin expanded to 17.4% from 15.6% in the prior year 10
New market 2024-05-07
Capital expenditure for new semiconductor production facility in Dresden initiated, with 90 to 100 million euros planned for a production building and office complex 10
Guidance initiated 2024-03-15
FY2024 guidance initiated: organic revenue growth in mid-single-digit percentage range; EBITDA margin 19.5-20.0% including approximately 0.5 percentage point charge for Dresden plant relocation 4
2023 · 11 events

2023-Q4 · Oct – Dec 2023

„Everything we do at Jenoptik is aimed at creating value for our stakeholders.“ – Dr. Stefan Traeger, Chairman/Chief Executive Officer 8
earnings 2024-03-27
Net income rose 28.8% to 73.5 million euros; earnings per share increased from 0.96 euros to 1.27 euros 5
Margin expanding 2024-03-15
FY EBITDA margin reached 19.7%, up from 18.8% in 2022, as EBITDA improved to 209.6 million euros 8

2023-Q3 · Jul – Sep 2023

Free cash flow turned positive ◦ 2023-11-08
9M free cash flow more than doubled to 56.9 million euros from 28.4 million euros in prior year 2
Revenue accelerating ◦ 2023-11-08
9M revenue increased 10.1% to 768.7 million euros with EBITDA margin improving to 18.6% from 16.9% in prior year 2
Guidance raised 2023-11-08
EBITDA margin guidance raised to around 19.5% for FY2023, from prior range of 19.0-19.5% 2

2023-Q2 · Apr – Jun 2023

Margin expanding 2023-08-09
H1 EBITDA margin improved to 18.1% from 15.6% in prior year as H1 EBITDA rose 31.6% to 91.6 million euros 6
Guidance confirmed 2023-08-08
FY2023 guidance confirmed: revenue 1,050-1,100 million euros and EBITDA margin 19.0-19.5% 1
Divestiture 2023-08-08
50% stake in HILLOS GmbH sold to Hilti Aktiengesellschaft; contract signed July 13, 2023 to acquire 33.34% stake in JENOPTIK Korea Corporation Ltd. 1

2023-Q1 · Jan – Mar 2023

earnings 2023-05-10
EBITDA rose 74.2% to 36.6 million euros with margin improving to 15.6% from 10.1% 3
Revenue accelerating ◦ 2023-05-10
Revenue increased 12.2% to 234.1 million euros, particularly driven by the Advanced Photonic Solutions division 3
Guidance confirmed 2023-05-10
FY2023 guidance confirmed: revenue 1,050-1,100 million euros and EBITDA margin 19.0-19.5% 3
Advertisement

Key Figures (€m)#

The company's core financial figures in three views, one below the other: fiscal years (as reported; after restatements the table shows the most recent filing version, marked), half-years (6-month basis, H2 = second half on its own) and quarters (3-month basis, not cumulative). Each row is one period, most recent first. Values with a dotted underline are clickable and show the raw value, the exact source location, the scale evidence and the source; derived values additionally show their formula and inputs. All values are extracted automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original.

All figures serve only to support your own investment decision and are not a recommendation; the company's original reports are authoritative.

Revenue (€m) · annual basis, as reported
FY2023FY2023: 1,0661,066FY2024FY2024: 1,1161,116FY2025FY2025: 1,0461,046
Net income (€m) · annual basis, as reported
FY2023FY2023: 7474FY2024FY2024: 9494FY2025FY2025: 7474
EPS (€) · annual basis, as reported
FY2023FY2023: 1.271.27FY2024FY2024: 1.621.62FY2025FY2025: 1.261.26
Operating cash flow (€m) · annual basis, as reported
FY2023FY2023: 167167FY2024FY2024: 167167FY2025FY2025: 196196
Revenue (€m) · quarterly basis, as reported
2024-Q32024-Q3: 2742742024-Q42024-Q4: 3013012025-Q12025-Q1: 2442442025-Q22025-Q2: 2552552025-Q32025-Q3: 2552552025-Q42025-Q4: 2932932026-Q12026-Q1: 2412412026-Q22026-Q2: 262262
Net income (€m) · quarterly basis, as reported
2024-Q32024-Q3: 27272024-Q42024-Q4: 27272025-Q12025-Q1: 992025-Q22025-Q2: 16162025-Q32025-Q3: 22222025-Q42025-Q4: 27272026-Q12026-Q1: 17172026-Q22026-Q2: 2323
EPS (€) · quarterly basis, as reported
2024-Q32024-Q3: 0.460.462024-Q42024-Q4: 0.470.472025-Q12025-Q1: 0.160.162025-Q22025-Q2: 0.260.262025-Q32025-Q3: 0.370.372025-Q42025-Q4: 0.460.462026-Q12026-Q1: 0.290.292026-Q22026-Q2: 0.400.40
Operating cash flow (€m) · quarterly basis, as reported
2024-Q32024-Q3: 41412024-Q42024-Q4: 59592025-Q12025-Q1: 45452025-Q22025-Q2: 19192025-Q32025-Q3: 53532025-Q42025-Q4: 79792026-Q12026-Q1: 23232026-Q22026-Q2: 3535
Cash (€m) · annual basis, as reported
FY2023FY2023: 6868FY2024FY2024: 8585FY2025FY2025: 55
Debt (€m) · annual basis, as reported
FY2023FY2023: 491491FY2024FY2024: 481481FY2025FY2025: 336336
Net Debt (€m) · annual basis, as reported
FY2023FY2023: 423423FY2024FY2024: 396396FY2025FY2025: 331331
Capex (€m) · annual basis, as reported
FY2023FY2023: 110110FY2024FY2024: 115115FY2025FY2025: 7777
FCF (€m) · annual basis, as reported
FY2023FY2023: 5757FY2024FY2024: 5252FY2025FY2025: 119119
D&A (€m) · annual basis, as reported
FY2023FY2023: 7171FY2024FY2024: 7575FY2025FY2025: 7777
Cash (€m) · quarterly basis, as reported
2024-Q32024-Q3: 58582024-Q42024-Q4: 85852025-Q12025-Q1: 50502025-Q22025-Q2: 41412025-Q32025-Q42025-Q4: 552026-Q12026-Q22026-Q2: 126126
Debt (€m) · quarterly basis, as reported
2024-Q32024-Q3: 4804802024-Q42024-Q4: 4814812025-Q12025-Q1: 4334332025-Q22025-Q2: 3863862025-Q32025-Q42025-Q4: 3363362026-Q12026-Q1: 3943942026-Q22026-Q2: 377377
Net Debt (€m) · quarterly basis, as reported
2024-Q32024-Q3: 4214212024-Q42024-Q4: 3963962025-Q12025-Q1: 3833832025-Q22025-Q2: 3443442025-Q32025-Q42025-Q4: 3313312026-Q12026-Q1: 3133132026-Q22026-Q2: 308308
Capex (€m) · quarterly basis, as reported
2024-Q32024-Q3: 26262024-Q42024-Q4: 42422025-Q12025-Q1: 14142025-Q22025-Q2: 18182025-Q32025-Q3: 26262025-Q42025-Q4: 19192026-Q12026-Q1: 10102026-Q22026-Q2: 1010
FCF (€m) · quarterly basis, as reported
2024-Q32024-Q3: 14142024-Q42024-Q4: 17172025-Q12025-Q1: 31312025-Q22025-Q2: 112025-Q32025-Q3: 27272025-Q42025-Q4: 60602026-Q12026-Q1: 13132026-Q22026-Q2: 2525
D&A (€m) · quarterly basis, as reported
2024-Q32024-Q3: 18182024-Q42024-Q4: 19192025-Q12025-Q1: 19192025-Q22025-Q2: 60602025-Q32025-Q42026-Q12026-Q2
Shown: the most recent fiscal years. Full history since FY2022 is on record.

Fiscal years

Amounts in €m · EPS in € per share · as reported
PeriodRevenueOp. incomeNet incomeEPS (€)OCFSource
FY20251,046°114.5EBIT74.21.2619627
FY20241,115.8°146.6EBIT94.21.62167.112
FY20231,066126.3EBIT73.51.27167115

Quarters

Amounts in €m · EPS in € per share · as reported
PeriodPublishedRevenueOp. incomeNet incomeEPS (€)FCFCashNet DebtSource
2026-Q2*2026-08-1126236EBIT22.90.40≈25.1126.4307.5128
2026-Q1*2026-06-30241.225.9EBIT16.80.29≈12.6–31329
2025-Q4*2025-06-30292.841.6EBIT27.30.46≈605.1~330.8~23
2025-Q3*2025-11-11254.833.3EBIT21.70.3727.2––18
2025-Q2*2025-08-12254.822.7EBIT16.10.260.841.3344.416
2025-Q1*2025-03-31243.616.9EBIT9.20.1630.750.2383.329
2024-Q4*2025-03-25300.742EBIT27.40.47≈16.984.9396.223
2024-Q3*2024-11-11274.340.9EBIT26.60.4614.4~57.9421.411
2024-Q2*2024-06-30284.737.7EBIT24.80.4220.2~60.1429.624
2024-Q1*2024-06-30256.126EBIT15.40.2715.656.5416.717
2023-Q4*2024-03-27297.338.2EBIT19.60.32≈49.467.7423.15
2023-Q3*2023-09-30263.834.3EBIT21.50.38≈17.2~34.6489.77
2023-Q2*2023-06-30270.833.9EBIT20.90.35≈-1349.1502.19
2023-Q1*2023-06-30234.119.9EBIT11.80.21≈25.4––103
* derived: values with formula provenance (hover); Q4 = FY − 9M · H2 = FY − H1 · EPS via implied shares · net debt = financial debt − cash · FCF = OCF − |capex|.
The publication date of individual rows is a publisher placeholder (not the actual publication date).
Columns not reported in this reporting cadence are hidden: Op. income (adj.), EBITDA (adj.), EPS adj. (not reported in any source for these periods).
Advertisement

Balance Sheet & Cash Flow (€m)#

Point-in-time balance sheet items (e.g. cash, financial debt) and cash flow items (operating cash flow, investments/capex) per fiscal year, half-year and quarter. Balance sheet values are as of the period end, flow items cover the period. Derived values are marked and are calculated, for example, as: net debt = financial debt − cash; free cash flow = operating cash flow − capex; the click popover shows formula and inputs. All values are extracted automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original.

Fiscal years

Amounts in €m · as reported
PeriodPublishedCashDebtNet DebtD&AOCFCapexFCFSource
FY20252025-06-305.1~335.9330.8~77.219677.4118.627
FY20242025-03-1984.9481.1396.2~74.9167.1114.652.512
FY20232023-12-3167.7490.8423.1~70.9167110.456.6115

Quarters

Amounts in €m · as reported
PeriodPublishedCashDebtNet DebtD&AOCFCapexFCFSource
2026-Q22026-08-11126.4376.7307.5–34.79.625.1128
2026-Q12026-06-30–394.2313–22.710.112.629
2025-Q42025-06-305.1~335.9330.8~–79.119.16023
2025-Q32025-11-11––––52.825.627.218
2025-Q22025-08-1241.3385.7344.459.51918.20.816
2025-Q12025-03-3150.2433.4383.319.345.114.430.729
2024-Q42025-03-2584.9481.1396.218.958.94216.923
2024-Q32024-11-1157.9480.1421.418.340.826.4~14.4~11
2024-Q22024-06-3060.1424.8429.619.335.114.9~20.2~24
2024-Q12024-06-3056.5–416.718.532.316.715.617
2023-Q42024-03-2767.7490.8423.119.781.932.549.45
2023-Q32023-09-3034.6524.3489.717.434.617.3~17.2~7
2023-Q22023-06-3049.1551.3502.117.16.219.1-139
2023-Q12023-06-30–––16.644.419.125.4103
Debt = long-term + current · Net debt = debt − cash · FCF = OCF − capex.
The publication date of individual rows is a publisher placeholder (not the actual publication date).
Advertisement

Revenue by Type (as of 2026-Q2 · EURm · 9/11)#

Revenue split by segment or product type, exactly as the company itself reports it. The basis is stated next to each value (3, 6 or 12 months); segment totals can deviate from group revenue (reconciliation/consolidation items). If the company changes its segment structure, older structures are kept in the expandable part. Rows in grey are no longer reported separately by the company; they show the last available figures and are never extrapolated.

SegmentSincePeriodBasisRevenueGrowthMarginSource
Semiconductor & Advanced Manufacturing2024-H12026-Q13M108.27.2%30.6%29
Biophotonics2024-H12026-Q13M56.8-10.9%21.9%29
Metrology & Production Solutions2024-H12026-Q13M39.1-3.7%-0.4%29
Smart Mobility SolutionsFY20222026-Q13M31.810.9%11.6%29
EuropeFY2024FY202512M564.3––19
AmericasFY2024FY202512M253.7––19
Asia/PacificFY2024FY202512M175.7––19
Middle East/AfricaFY2024FY202512M52.3––19
OtherFY2022FY202512M29.9––27
Advanced Photonic SolutionsFY2022FY20243M–5.6%21.8%15
Non-Photonic Portfolio CompaniesFY2022FY20243M–4%17.5%15
Advertisement

Products & M&A (9/20 active+recent)#

Product announcements from the reports; market launches, approvals, partnerships; with first mention (date) and source. “Active/current” means: still mentioned in the most recent reports; what the company no longer mentions moves to the expandable part but is never deleted. Rows in grey are discontinued products.

Product/LineSinceStatusSource
New high-tech fab at Airportpark Dresden2025-01Launched8
Traffic enforcement systems deployment in Jordan2025Launched27
Semiconductor optics production capacity expansion at Jena (3x)2025Launched27
MS-I2 multispectral illumination and imaging solution2025Launched27
MBSS Modular Beam Splitting System2025Launched27
F-Theta lens for additive manufacturing (2x)2025Launched22
Expansion of production capacities for high-quality classic semiconductor optics at headquarters in Jena2025Launched20
Expansion of human rights audits within supply chain planned2025Planned15
Dresden factory expansion (8x)2025Launched20
JENscan Style translucent technology first delivery2024-08Launched15
400th JENOPTIK-VOTAN® A system delivery2024-07Launched15
Regional matrix dissolution and verticalization in Advanced Photonic Solutions2024Launched4
On-site human rights audits initiated2024Launched15
PSS-40/LCLW test station innovation award at Blechexpo2023-11Launched8
UFO Probe Card development for wafer-level photonic integrated circuit testing2023Launched8
JENar Silverline lens launch for laser material processing of solar cells2023Launched8
JENOPTIK Industrial Metrology Germany GmbH integrated management system recertification (ISO 9001/ISO 14001/ISO 45001)2023Launched8
JENOPTIK Automatisierungstechnik GmbH ISO 14001 certification2023Launched8
Berlin medical technology site (4x)2023Launched1
Advertisement

M&A (16)#

All recorded acquisitions (purchases) and divestitures/exits with date, short description and source; deliberately including smaller transactions that summaries often miss. Purchase prices appear only where the company itself has disclosed them. Rows in grey are cancelled transactions; the cancellation date is shown in the row.

Acquisitions · 7Divestitures/exits · 7older: 2 (in the table)
202420252026

Acquisitions

Transaction / stakeDateTypeSource
New debenture bond tranches (150 million euros total)2026-04Completed28
UAB Fima ITS (now UAB JENOPTIK Baltic)2026-03Completed28
Cleanroom factory in Dresden (5x)2024-01Completed27
TELSTAR-HOMMEL Corporation Ltd. stake sale (8x)2023Completed8
Prodomax major welding robots order for North America (2x)2023Completed2
Goodwill reallocation to HOMMEL ETAMIC and Prodomax2023Completed8
BG Medical GmbH acquisition2023Completed8
Jenoptik joined the UN Global Compact2021Completed15

Divestitures / exits

Transaction / stakeDateTypeSource
HOMMEL ETAMIC internal development instead of divestiture2024-06Divested11
Prodomax sale (4x)2024Divested16
Sale of 50-percent stake in HILLOS GmbH to Hilti Aktiengesellschaft2023-06Divested8
HILLOS GmbH stake sale2023-06Divested1
Prodomax divestiture2023Divested8
Medium-term intention to sell Prodomax2023Divested8
Automation & Integration business (Prodomax brand) disposal2023Divested8
VINCORION discontinued operation deconsolidation2022-06Divested8
Advertisement

Reported KPIs (as disclosed) (402)#

Figures the company discloses itself in addition to the standard financials; order intake, recurring revenue, user or unit counts, adjusted measures. These “story KPIs” usually slip through standard databases; here they are collected as reported, with no calculation of our own. Important: the definition comes from the company itself and can differ from firm to firm; period and source are stated next to every value.

Company-specific KPIs verbatim from the filings (English, as disclosed; not normalised). Balance-sheet and boilerplate items filtered.
DatePeriodKPIValue / changeSource
2026-08-112026-Q2Working capital ratio32.328
2026-08-112026-Q2Order backlog824.8 (EUR in million euros)28
2026-08-112026-Q2Leverage (Net debt/EBITDA)1.4x28
2026-08-112026-Q2Gross margin36.128
2026-08-112026-Q2Equity ratio58.428
2026-08-112026-Q2EBITDA margin19.728
2026-08-112026-Q2EBIT margin12.328
2026-08-112026-Q2Cash conversion rate47.728
2026-08-112026-Q2Book-to-bill ratio1.4428
2026-05-112026-Q1Working capital ratio31.829
2026-05-112026-Q1Order backlog719.2 (EUR in million euros)29
2026-05-112026-Q1Leverage1.6x29
2026-05-112026-Q1Gross margin35.429
2026-05-112026-Q1Equity ratio60.429
2026-05-112026-Q1EBITDA margin18.429
2026-05-112026-Q1Cash conversion rate35.929
2026-05-112026-Q1Book to bill ratio1.4829
2026-03-18FY2025Working capital ratio29.127
2026-03-18FY2025Working capital304.6 (EUR million euros)27
2026-03-18FY2025Work related illnesses227
2026-03-18FY2025Work related accidents rate4.527
2026-03-18FY2025Work related accidents count3227
2026-03-18FY2025Women in middle senior management33.327
2026-03-18FY2025Suppliers medium sizedapproximately 2027
2026-03-18FY2025Suppliers global base countries5727
2026-03-18FY2025Supplier audits conducted4527
2026-03-18FY2025Renewable electricity share96.8 %27
2026-03-18FY2025Personnel expenses404.8 (EUR million euros)27
2026-03-18FY2025Payout ratio31.7²27
2026-03-18FY2025Organic revenue growth-6.3%27
2026-03-18FY2025Order backlog590.8 (EUR million euros)27
2026-03-18FY2025Lost workdays29027
2026-03-18FY2025Leverage1.627
2026-03-18FY2025Highest paid to median ratio19.727
2026-03-18FY2025Gross profit336.3 (EUR million euros)27
2026-03-18FY2025Fines for corruption027
2026-03-18FY2025Fatal work accidents027
2026-03-18FY2025Equity ratio60.227
2026-03-18FY2025Dividend yield2.0²27
2026-03-18FY2025Dividend per share0.40²27
2026-03-18FY2025Debt-to-equity ratio0.6627
2026-03-18FY2025CSR rate6427
2026-03-18FY2025Corruption and bribery cases027
2026-03-18FY2025Cash conversion rate79.2%27
2026-03-18FY2025Voluntary turnover rate4.5 %27
2026-03-18FY2025Turnover rate9.6 %27
2026-03-18FY2025Trainees and dual-study students20127
2026-03-18FY2025Trainees and dual-study students (prior year)17827
2026-03-18FY2025Trainees and dual-study students20127
2026-03-18FY2025Total training hours38,991 hours27
2026-03-18FY2025Total renewable energy consumption50,59827
2026-03-18FY2025Total indirect (Scope 3) GHG emissions197,025 t CO2e27
2026-03-18FY2025Total energy consumption72,29327
2026-03-18FY2025Taxonomy-eligible revenue share40.5 %27
2026-03-18FY2025Taxonomy-eligible OpEx share48.5 %27
2026-03-18FY2025Taxonomy-eligible CapEx share55.0 %27
2026-03-18FY2025Taxonomy-aligned revenue share0.0 %27
2026-03-18FY2025Taxonomy-aligned OpEx share0.0 %27
2026-03-18FY2025Taxonomy-aligned CapEx share0.0 %27
2026-03-18FY2025Share of renewable sources in total energy consumption70.0 %27
2026-03-18FY2025Scope 2 GHG emissions (location-based)1,267 t CO2e27
2026-03-18FY2025Scope 1 GHG emissions2,903 t CO2e27
2026-03-18FY2025Reports related to human rights violations027
2026-03-18FY2025Reports related to discrimination issues1527
2026-03-18FY2025ROCE prior year10.8%27
2026-03-18FY2025ROCE8.4%27
2026-03-18FY2025R&D ratio 2 prior year5.7%27
2026-03-18FY2025R&D ratio 25.9%27
2026-03-18FY2025R&D ratio 1 prior year9.5%27
2026-03-18FY2025R&D ratio 110.6%27
2026-03-18FY2025R&D output prior year106.5 million euros27
2026-03-18FY2025R&D output111.2 million euros27
2026-03-18FY2025Proportion of women prior year30.3%27
2026-03-18FY2025Proportion of women30.6%27
2026-03-18FY2025Proportion of employees abroad prior year36.1%27
2026-03-18FY2025Proportion employees abroad36.0%27
2026-03-18FY2025Property plant equipment net prior year419,91727
2026-03-18FY2025Property plant equipment net426,19627
2026-03-18FY2025Plan assets prior year136,078 (EUR in thousand euros)27
2026-03-18FY2025Plan assets144,419 (EUR in thousand euros)27
2026-03-18FY2025Other reports related to social factors1327
2026-03-18FY2025Order backlog prior year670.1 million euros27
2026-03-18FY2025Order backlog590.8 (EUR in million euros)27
2026-03-18FY2025Order backlog590.8 million euros27
2026-03-18FY2025Leverage1.6x27
2026-03-18FY2025Lease ROU assets net prior year62,042 (EUR in thousand euros)27
2026-03-18FY2025Lease ROU assets net65,617 (EUR in thousand euros)27
2026-03-18FY2025Interns927
2026-03-18FY2025Gross margin prior year33.4%27
2026-03-18FY2025Gross margin32.1%27
2026-03-18FY2025GHG intensity (market-based)192.4 t CO2e/million euros revenue27
2026-03-18FY2025GHG intensity (location-based)207.0 t CO2e/million euros revenue27
2026-03-18FY2025GHG emissions Scope 1+2 reduction vs 201959.0 %27
2026-03-18FY2025Equity ratio60.227
2026-03-18FY2025Equity ratio60.2%27
2026-03-18FY2025Energy intensity (climate-intensive sectors)69.127
2026-03-18FY2025Employees abroad prior year1,67727
2026-03-18FY2025Employees abroad1,60227
2026-03-18FY2025EBITDA margin prior year19.9%27
2026-03-18FY2025EBITDA margin18.4%27
2026-03-18FY2025EBIT margin prior year13.1%27
2026-03-18FY2025EBIT margin10.9%27
2026-03-18FY2025Dividend per share0.4027
2026-03-18FY2025Defined benefit obligations prior year143,19827
2026-03-18FY2025Defined benefit obligations148,72727
2026-03-18FY2025Debt to equity ratio prior year0.8027
2026-03-18FY2025Debt to equity ratio0.6627
2026-03-18FY2025Coverage rate of employees44.0 %27
2026-03-18FY2025Contract liabilities prior year60,30827
2026-03-18FY2025Contract liabilities52,81927
2026-03-18FY2025Contract asset prior year86,835 (EUR in thousand euros)27
2026-03-18FY2025Contract asset83,997 (EUR in thousand euros)27
2026-03-18FY2025Confirmed cases of discrimination227
2026-03-18FY2025Combined Scope 1 and market-based Scope 2 GHG emissions4,171 t CO2e27
2026-03-18FY2025Cash conversion rate prior year46.5%27
2026-03-18FY2025Cash conversion rate79.227
2026-03-18FY2025Cash conversion rate79.2%27
2026-03-18FY2025CO2 emissions Scope 1 2 20254,171 t CO2e27
2026-03-18FY2025Book to bill ratio prior year0.9227
2026-03-18FY2025Book to bill ratio0.9527
2026-03-18FY2025Available liquidity prior yearapproximately 480 million euros27
2026-03-18FY2025Available liquidityapproximately 480 million euros27
2026-03-18FY2025Agency workers4227
2026-03-18FY2025Absenteeism rate Germany prior year5.8%27
2026-03-18FY2025Absenteeism rate Germany5.8%27
–FY2025Net debt to EBITDA1.6x22
–FY2025market capitalization year end1,120.1 (EUR million euros)22
–FY2025Equity ratioaround 60 percent20
–FY2025Equity ratio60 percent22
–FY2025Dividend per share0.40 euros20
–FY2025Dividend per share0.4022
–FY2025CO2 emissions reduction59 percent20
2026-03-182025-Q4Working capital304,578 (EUR in thousand euros)19
2026-03-182025-Q4Order backlog590,762 (EUR in thousand euros)19
2026-03-182025-Q4Unused credit facility398,02619
2026-03-182025-Q4Total financial liabilities500,61419
2026-03-182025-Q4Total financial assets219,198 (EUR in thousand euros)19
2025-11-122025-Q3Order backlog658.9 (EUR in million euros)26
2025-11-112025-Q3Working capital ratio30.318
2025-11-112025-Q3Working capital319.8 (EUR in million euros)18
2025-11-112025-Q3Unused credit lines37018
2025-11-112025-Q3Order backlog658.9 (EUR in million euros)18
2025-11-112025-Q3Net debt366.3 (EUR in million euros)18
2025-11-112025-Q3Leverage1.918
2025-11-112025-Q3Gross margin31.918
2025-11-112025-Q3Equity ratio59.118
2025-11-112025-Q3Cash conversion rate64.218
2025-11-112025-Q3Cash and cash equivalents51.0 (EUR in million euros)18
2025-11-112025-Q3Book-to-bill ratio Q31.2018
2025-11-112025-Q3Book-to-bill ratio1.0318
2025-11-112025-Q3EBITDA margin17.518
2025-11-112025-Q3EBIT margin9.718
2025-08-132025-H1Order backlog612.7 (EUR in million euros)24
2025-08-122025-Q2Working capital ratio30.3%16
2025-08-122025-Q2Working capital325.5 million euros16
2025-08-122025-Q2Revenue share abroad73.6%16
2025-08-122025-Q2Order backlog612.7 million euros16
2025-08-122025-Q2Leverage2.0x16
2025-08-122025-Q2Equity ratio58.3%16
2025-08-122025-Q2Cash conversion rate54.9%16
2025-08-122025-Q2Book-to-bill ratio0.9516
2025-05-122025-Q1Working capital320.0 (EUR millions)17
2025-05-122025-Q1Order backlog622.2 (EUR millions)17
2025-05-122025-Q1Net debt382.2 (EUR millions)17
2025-05-122025-Q1Leverage (net debt/EBITDA)1.8x17
2025-05-122025-Q1Gross margin30.9 percent17
2025-05-122025-Q1Equity ratio57.7 percent17
2025-05-122025-Q1EBITDA margin14.9 percent17
2025-05-122025-Q1EBIT margin6.9 percent17
2025-05-122025-Q1Cash conversion rate79.8 percent17
2025-05-122025-Q1Book-to-bill ratio0.8417
2025-03-312025-Q1Order backlog622.2 (EUR in million euros)25
2025-03-19FY2024Working capital ratio28.615
2025-03-19FY2024Working capital318.8 (EUR million euros)15
2025-03-19FY2024Work related illnesses015
2025-03-19FY2024Women supervisory board50 percent15
2025-03-19FY2024Women ratio30.315
2025-03-19FY2024Women in mid-senior management count1115
2025-03-19FY2024Women in mid-senior management30.6 %15
2025-03-19FY2024Women first management level29.2 percent15
2025-03-19FY2024Trainees and Dual Study Students17815
2025-03-19FY2024Trainees17815
2025-03-19FY2024Total Training Hours27,524 hours15
2025-03-19FY2024Total Opex Prior Year86.3 million euros15
2025-03-19FY2024Total Opex92.0 million euros15
2025-03-19FY2024Total Indirect Scope 3 Greenhouse Gas Emissions 2024285,705 t CO2eq15
2025-03-19FY2024Total Greenhouse Gas Emissions Site-Specific 2024304,391 t CO2eq15
2025-03-19FY2024Total Greenhouse Gas Emissions Market-Specific 2024290,198 t CO2eq15
2025-03-19FY2024Total Family Leave Utilization %5.5 %15
2025-03-19FY2024Taxonomy-Eligible Revenue Share Prior Year38.7 %15
2025-03-19FY2024Taxonomy-Eligible Revenue Share37.4 %15
2025-03-19FY2024Taxonomy-Eligible Opex Share40.8 %15
2025-03-19FY2024Taxonomy-Eligible Opex Share Prior Year37.6 million euros15
2025-03-19FY2024Taxonomy-Eligible Opex37.5 million euros15
2025-03-19FY2024Taxonomy-Eligible Capex Share57.6 %15
2025-03-19FY2024Taxonomy-Eligible Capex Prior Year41.1 million euros15
2025-03-19FY2024Taxonomy-Eligible Capex66.0 million euros15
2025-03-19FY2024Site-Specific Scope 2 Greenhouse Gas Emissions 202416,190 t CO2eq15
2025-03-19FY2024Scope 3 Category 2 Capital Goods 202433,750 t CO2eq15
2025-03-19FY2024Scope 3 Category 11 Use of Sold Products 202454,945 t CO2eq15
2025-03-19FY2024Scope 3 Category 1 goods and services purchased 2024197,010 t CO2eq15
2025-03-19FY2024Scope 1 greenhouse gas emissions 20242,496 t CO2eq15
2025-03-19FY2024Scope 1 greenhouse gas emissions 20192,254 t CO2eq15
2025-03-19FY2024Scope 1 and market-based Scope 2 combined 20244,493 t CO2eq15
2025-03-19FY2024Scope 1 and market-based Scope 2 combined 20235,031 t CO2eq15
2025-03-19FY2024Scope 1 and market-based Scope 2 combined 201910,161 t CO2eq15
2025-03-19FY2024Reportable occupational accidents3615
2025-03-19FY2024Personnel expenses399.6 (EUR million euros)15
2025-03-19FY2024Payout ratio on earnings23.5²15
2025-03-19FY2024Pay ratio highest to median2215
2025-03-19FY2024Other compliance reports1615
2025-03-19FY2024Order intake1,027.7 (EUR million euros)15
2025-03-19FY2024Order backlog670.1 (EUR million euros)15
2025-03-19FY2024Occupational accident rate per million hours4.915
2025-03-19FY2024New trainees and dual study students hired6415
2025-03-19FY2024Men in mid-senior management count2515
2025-03-19FY2024Men in mid-senior management69.4 %15
2025-03-19FY2024Market-based Scope 2 greenhouse gas emissions 20241,997 t CO2eq15
2025-03-19FY2024Market-based Scope 2 greenhouse gas emissions 20192,778 t CO2eq15
2025-03-19FY2024Male employees family leave utilization %4.7 %15
2025-03-19FY2024Male employees family leave utilization12915
2025-03-19FY2024Leverage1.815
2025-03-19FY2024Interns2615
2025-03-19FY2024independent shareholder representatives83.3 percent15
2025-03-19FY2024gross profit margin33.415
2025-03-19FY2024fines penalties corruption015
2025-03-19FY2024female employees family leave utilization percentage7.6 %15
2025-03-19FY2024female employees family leave utilization8215
2025-03-19FY2024fatal occupational accidents015
2025-03-19FY2024Equity ratio55.615
2025-03-19FY2024Dividend yield1.7²15
2025-03-19FY2024Dividend per share0.38²15
2025-03-19FY2024discrimination and harassment reports715
2025-03-19FY2024Debt-to-equity ratio0.8015
2025-03-19FY2024corruption incidents015
2025-03-19FY2024collective agreement coverage percentage43.8 %15
2025-03-19FY2024collective agreement coverage headcount2,03315
2025-03-19FY2024Cash conversion rate46.515
2025-03-19FY2024capital expenditure114.6 (EUR millions)12
2025-03-19FY2024book to bill ratio total0.9215
2025-03-19FY2024book to bill ratio SMS1.0315
2025-03-19FY2024book to bill ratio NPPC0.7015
2025-03-19FY2024book to bill ratio APS0.9415
2025-03-19FY2024Book-to-bill ratio0.7015
2025-03-19FY2024average training hours total5.9215
2025-03-19FY2024average supervisory board length of service4.0 years15
2025-03-19FY2024average supervisory board age52.5 years15
2025-03-19FY2024agency workers3815
2025-03-19FY2024absenteeism rate5.815
2025-03-19FY2024Working capital318,760 (EUR in thousand euros)15
2025-03-19FY2024Training rate3.8 %15
2025-03-19FY2024Total energy consumption68,51215
2025-03-19FY2024TRIOPTICS China Hong Kong Total comprehensive income3,639 (EUR in thousand euros)15
2025-03-19FY2024TRIOPTICS China Hong Kong Revenue31,446 (EUR in thousand euros)15
2025-03-19FY2024TRIOPTICS China Hong Kong Other comprehensive income319 (EUR in thousand euros)15
2025-03-19FY2024TRIOPTICS China Hong Kong Non-current liabilities26515
2025-03-19FY2024TRIOPTICS China Hong Kong Non-current assets1,562 (EUR in thousand euros)15
2025-03-19FY2024TRIOPTICS China Hong Kong Net assets7,811 (EUR in thousand euros)15
2025-03-19FY2024TRIOPTICS China Hong Kong Earnings after tax3,32015
2025-03-19FY2024TRIOPTICS China Hong Kong Current liabilities9,25615
2025-03-19FY2024TRIOPTICS China Hong Kong Current assets15,771 (EUR in thousand euros)15
2025-03-19FY2024TRIOPTICS China Hong Kong Cash flows from operating activities5,664 (EUR in thousand euros)15
2025-03-19FY2024TRIOPTICS China Hong Kong Cash flows from financing activities-2,777 (EUR in thousand euros)15
2025-03-19FY2024ROCE10.815
2025-03-19FY2024R&D ratio 25.715
2025-03-19FY2024R&D ratio 19.515
2025-03-19FY2024R&D output106.515
2025-03-19FY2024R&D expenses64.0 (EUR million euros)15
2025-03-19FY2024Portion of green electricity95.8 %15
2025-03-19FY2024Plan assets136,078 (EUR in thousand euros)15
2025-03-19FY2024Organic revenue growth4.7%15
2025-03-19FY2024Order backlog670,079 (EUR in thousand euros)15
2025-03-19FY2024Indirect emissions Scope 21,997 t CO2eq15
2025-03-19FY2024GHG emissions per 1 million euros revenue (site-specific)27.3 t CO2eq/million euros15
2025-03-19FY2024GHG emissions per 1 million euros revenue (market-specific)26.0 t CO2eq/million euros15
2025-03-19FY2024GHG emissions Scope 1+24,493 t CO2eq15
2025-03-19FY2024Free cash flow102.9 million15
2025-03-19FY2024Equity ratio55.615
2025-03-19FY2024Engagement score76 %15
2025-03-19FY2024Energy intensity per net revenue61.4 (EUR MWh/currency unit)15
2025-03-19FY2024EBITDA margin19.9 %12
2025-03-19FY2024EBITDA margin19.915
2025-03-19FY2024EBITDA margin19.915
2025-03-19FY2024EBITDA221.5 (EUR millions)12
2025-03-19FY2024EBITDA221.5 million15
2025-03-19FY2024EBIT margin13.115
2025-03-19FY2024EBIT margin13.115
2025-03-19FY2024Dividend per share0.38 euros15
2025-03-19FY2024Direct emissions Scope 12,496 t CO2eq15
2025-03-19FY2024Defined benefit obligations (DBO)143,19815
2025-03-19FY2024Contract liabilities60,30815
2025-03-19FY2024Contract assets86,835 (EUR in thousand euros)15
2025-03-19FY2024Cash conversion rate46.515
2025-03-19FY2024CSR rate60.9 %15
2025-03-19FY2024CSR rate61 percent15
2025-03-19FY2024CO₂ reduction vs. base year 201955.8 %15
2025-03-252024-Q4Order backlog670.1 (EUR in million euros)14
2024-11-112024-Q3Working capital ratio30.111
2024-11-112024-Q3Working capital335.3 (EUR in million euros)11
2024-11-112024-Q3R&D output77.511
2024-11-112024-Q3Order backlog709.2 (EUR in million euros)11
2024-11-112024-Q3Leverage (net debt/EBITDA)1.9 (EUR x)11
2024-11-112024-Q3Gross margin33.911
2024-11-112024-Q3Equity ratio55.911
2024-11-112024-Q3EBITDA margin19.711
2024-11-112024-Q3EBIT margin12.811
2024-11-112024-Q3Cash conversion rate38.811
2024-11-112024-Q3Book-to-bill ratio0.9611
2024-08-092024-H1Order backlog734.1 (EUR in million euros)13
2024-08-092024-H1EBITDA margin18.813
2024-08-092024-H1EBIT margin11.813
2024-08-092024-H1Cash conversion rate40.913
2024-08-082024-Q2Working capital ratio29.29
2024-08-082024-Q2Working capital321.6 (EUR in million euros)9
2024-08-082024-Q2Order backlog734.1 (EUR in million euros)9
2024-08-082024-Q2Leverage net debt EBITDA2.0x9
2024-08-082024-Q2Equity ratio54.29
2024-08-082024-Q2Cash conversion rate40.99
2024-08-082024-Q2Book-to-bill ratio0.979
2024-08-082024-Q2EBITDA margin18.89
2024-08-082024-Q2EBIT margin11.89
2024-05-072024-Q1Working capital312.9 (EUR in million euros)10
2024-05-072024-Q1Order backlog731.3 (EUR in million euros)10
2024-05-072024-Q1Leverage (net debt to EBITDA)1.9x10
2024-05-072024-Q1Equity ratio54.310
2024-03-27FY2023Order backlog745.0 (EUR in million euros)5
2024-03-15FY2023Workplace accidents group5.58
2024-03-15FY2023Workplace accidents Germany11.68
2024-03-15FY2023Working capital304.4 (EUR in million euros)8
2024-03-15FY2023Women career index score868
2024-03-15FY2023Water consumption92,4448
2024-03-15FY2023Waste recycling rate38.68
2024-03-15FY2023Trainees employed1638
2024-03-15FY2023Trainee retention rate88.08
2024-03-15FY2023Taxonomy-Eligible Revenue Share38.78
2024-03-15FY2023Taxonomy-eligible revenue412.1 (EUR million euros)8
2024-03-15FY2023Taxonomy-Eligible Opex Share43.68
2024-03-15FY2023Taxonomy-Eligible Opex37.6 (EUR million euros)8
2024-03-15FY2023Taxonomy-Eligible Capex Share37.38
2024-03-15FY2023Taxonomy-Eligible Capex41.1 (EUR million euros)8
2024-03-15FY2023Scope 3 emissionsaround 300,0008
2024-03-15FY2023parental leave germany1558
2024-03-15FY2023order backlog recognition 202486.7 (EUR %)4
2024-03-15FY2023Order backlog744.9 (EUR in million euros)8
2024-03-15FY2023non-hazardous waste1,1278
2024-03-15FY2023hazardous waste1958
2024-03-15FY2023green electricity proportion93.68
2024-03-15FY2023Equity ratio54.28
2024-03-15FY2023energy efficiency63.38
2024-03-15FY2023energy consumption67,4778
2024-03-15FY2023cash conversion rate 202360.84
2024-03-15FY2023Cash conversion rate60.88
2024-03-15FY2023ROCE9.6 percent8
2024-03-15FY2023R&D ratio8.9 percent8
2024-03-15FY2023R&D expenses to revenue5.7 percent8
2024-03-15FY2023Order backlog745.0 (EUR million euros)8
2024-03-15FY2023Gross margin34.8 percent8
2024-03-15FY2023Equity ratio54.28
2024-03-15FY2023EBITDA margin guidance 202419.5 to 20.04
2024-03-15FY2023EBITDA margin 202319.74
2024-03-15FY2023EBITDA margin19.78
2024-03-15FY2023EBITDA margin19.78
2024-03-15FY2023EBIT margin11.98
2024-03-15FY2023Cash conversion rate60.88
2024-03-15FY2023CSR rate49.08
2024-03-15FY2023CO2 emissions scope 1+25,0318
2024-03-15FY2023CO2 emissions reduction vs. 201950.58
2024-03-15FY2023Book-to-bill ratio1.028
2023-11-082023-Q3Working capital ratio30.7%2
2023-11-082023-Q3Leverage (net debt to EBITDA)2.3 (EUR millions)2
2023-11-082023-Q3Equity ratio52.3%2
2023-11-082023-Q3EBITDA margin18.6%2
2023-11-082023-Q3Cash conversion rate39.8%2
2023-11-082023-Q3Book-to-bill ratio1.092
2023-09-302023-Q3Order backlog794.9 (EUR in million euros)7
2023-09-302023-Q3EBITDA margin (Jul.-Sep. 2023)19.5%7
2023-09-302023-Q3EBITDA margin (Jul.-Sep. 2022)19.2%7
2023-09-302023-Q3EBITDA margin (Jan.-Sep. 2023)18.6%7
2023-09-302023-Q3EBITDA margin (Jan.-Sep. 2022)16.9%7
2023-09-302023-Q3EBIT margin (Jul.-Sep. 2023)13.0%7
2023-09-302023-Q3EBIT margin (Jul.-Sep. 2022)12.6%7
2023-09-302023-Q3EBIT margin (Jan. - Sept. 2023)11.5%7
2023-09-302023-Q3EBIT margin (Jan. - Sept. 2022)9.8%7
2023-09-302023-Q3Cash conversion rate (July - Sept. 2023)59.7%7
2023-09-302023-Q3Cash conversion rate (July - Sept. 2022)32.6%7
2023-09-302023-Q3Cash conversion rate (Jan. - Sept. 2023)39.8%7
2023-09-302023-Q3Cash conversion rate (Jan. - Sept. 2022)24.1%7
2023-08-082023-Q2Working capital ratio30.2%1
2023-08-082023-Q2Leverage (net debt/EBITDA)2.4 (EUR thousands)1
2023-08-082023-Q2Equity ratio50.9%1
2023-08-082023-Q2EBITDA margin18.1%1
2023-08-082023-Q2EBIT margin10.7%1
2023-08-082023-Q2Cash conversion rate28.5%1
2023-08-082023-Q2Book-to-bill ratio1.081
2023-05-102023-Q1Working capital283.2 (EUR in million euros)3
2023-05-102023-Q1Order backlog776.1 (EUR in million euros)3
2023-05-102023-Q1Net debt465.5 (EUR in million euros)3
2023-05-102023-Q1Leverage2.33
2023-05-102023-Q1Equity ratio50.6%3
2023-05-102023-Q1EBITDA margin15.6%3
2023-05-102023-Q1Cash conversion rate78.0%3
2023-05-102023-Q1Book-to-bill ratio1.213
Advertisement

Guidance Tracking (latest per metric/period · 7/14)#

All management forecasts (guidance) and their later outcome. Types: fiscal-year targets as well as quarterly/half-year targets; per metric and period the most recent statement applies, older versions can be expanded. The status is checked automatically against the actuals reported later: open (period still running), met, beaten, missed. For ranges (“X to Y”) reaching the range counts. Logged neutrally, no estimate of our own, no assessment.

Actuals: revenue in €m · ratios in %

For periodGuided onMetricGuidedActualVerdictDirectionSource
FY20262026-08-11Revenueupper half of single-digit percentage range–pendingraised28
FY20262026-08-11EBITDA margin20–21%–pendingraised28
FY20262026-05-11Capex77.4–pendingconfirmed28
FY2026–EBITDA19–21–pendingraised22
FY20252025-11-11Capex114.677.4misscut18
FY20252025-11-11EBITDA margin18–19.5%18.4in lineconfirmed18
FY20252025-05-12Revenue51,046–confirmed18
FY20242024-05-07Revenuemid-single-digit percentage range1,115.8–confirmed11
FY20242024-03-15CapexSlightly above prior-year level114.6–initiated4
FY20242024-03-15EBITDA19.5–20221.5–initiated4
FY20242024-03-15EBITDA margin19.5–20%19.9in lineconfirmed11
FY20242024-03-15cash_conversion_rate50––initiated4
FY20232023-11-08EBITDA margin19.5%19.7beatraised8
FY20232023-05-10Revenue1,050–1,1001,066in lineconfirmed8
Advertisement

Development#

A condensed summary per reporting period as running text: what changed operationally, which drivers management names, how earnings and cash flow developed. Most recent period first, grouped by year; each text is written from the original report of that period, superscript numbers lead to the source.

FY2026

In the first half of fiscal year 2026, Jenoptik reported revenue of 241.2 million euros in Q1 and 262 million euros in Q2, with Semiconductor & Advanced Manufacturing as the primary growth driver in both quarters while Biophotonics and Metrology & Production Solutions experienced revenue declines 29 28. Order intake rose 74.4% to 356.9 million euros in Q1 29, and cumulative H1 order intake reached 723.4 million euros, a 53.0% increase year on year, lifting the order backlog to 824.8 million euros with a book-to-bill ratio of 1.44 at end of Q2 28. Net income was 16.8 million euros in Q1 29 and 22.9 million euros in Q2 28, with the EBITDA margin expanding from 15.8% in the prior-year second quarter to 19.7% in Q2 2026 28. The Executive Board raised its full-year guidance in Q2 to expect revenue in the upper half of the previous single-digit percentage range and an EBITDA margin of 20.0-21.0% 28.

FY2025

Jenoptik generated full-year 2025 revenue of 1,046 million euros, a decline of 6.3 percent year-over-year, reflecting weaker demand in the semiconductor equipment supply chain and the challenging North American automotive market 27. Effective January 1, 2025, the group reorganized into four Strategic Business Units (Semiconductor & Advanced Manufacturing, Biophotonics, Metrology & Production Solutions, and Smart Mobility Solutions), replacing the prior matrix structure; Biophotonics and Smart Mobility Solutions delivered revenue growth while the other two units reported lower sales 27. Net income came in at 74.2 million euros, with diluted earnings per share of 1.26 euros; earnings per share declined 22.2 percent compared with the prior year 23. The EBITDA margin stood at 18.4 percent for the full year, within the forecast range, as cost-reduction measures partially offset the revenue decline 27. Free cash flow before interest and taxes improved approximately 50 percent to 152.4 million euros, aided by higher operating cash flows and reduced capital expenditure following completion of the Dresden micro-optics factory; the equity ratio strengthened to 60.2 percent and net debt-to-EBITDA leverage improved to 1.6 times from 1.8 times 27.

FY2024

Jenoptik grew full-year revenue by 4.7% to 1,115.8 million euros in 2024, driven primarily by the Advanced Photonic Solutions division, particularly in the semiconductor equipment business 15. The EBITDA margin for the year reached 19.9%, finishing at the upper end of the guidance range of 19.5 to 20.0 percent 15. Diluted earnings per share increased 27.6% to 1.62 euros, while full-year free cash flow was lower than the prior year, largely due to higher capital expenditure for the new cleanroom factory in Dresden 15. Order intake declined 5.9% to 1,027.7 million euros and the order backlog decreased to 670.1 million euros from 745.0 million euros at year-end 2023 15. In November 2024, the Group announced it was postponing previously communicated 2025 financial targets to 2026, citing a challenging market environment 11.

FY2023

Jenoptik AG grew full-year revenue organically by 8.7 percent to 1,066 million euros in 2023, with particularly strong demand in the semiconductor equipment business within the Advanced Photonic Solutions division 8. EBITDA reached 209.6 million euros with a margin of 19.7 percent, up from 18.8 percent in 2022, while net income rose 28.8 percent to 73.5 million euros 5 8. The Advanced Photonic Solutions division was the primary revenue driver, reaching 821.2 million euros with an EBITDA margin of 21.9 percent, while Non-Photonic Portfolio Companies reported EBITDA of 17.6 million euros versus 3.6 million euros in the prior year 8. Net debt declined to 423.1 million euros from 479.0 million euros in the prior year, with the net debt to EBITDA leverage ratio improving to 2.0 from 2.6 and the equity ratio reaching 54.2 percent 8. For 2024, management guided organic revenue growth in the mid-single-digit percentage range and an EBITDA margin of 19.5 to 20.0 percent, noting an approximately 0.5 percentage point charge for the planned Dresden facility relocation 8.

Advertisement

Glossary#

  • Revenue: Revenue from contracts with customers, net of sales deductions, as the company itself reports it; not total output, gross revenue, GMV or order intake.
  • Op. income: The operating line of the income statement; EBIT only as a marked fallback, never pre-tax or ordinary income.
  • Net income: Net income attributable to the shareholders of the parent, after discontinued operations; not the result including minority interests, not comprehensive income.
  • EPS: Diluted earnings per share attributable to the shareholders of the parent; a printed figure always beats a calculated one, calculated values are marked.
  • FCF: Free cash flow = operating cash flow minus capital expenditure on property, plant and equipment; the company's own free cash flow figure is shown separately.
  • OCF: Cash flow from operating activities as reported; IFRS companies may show interest paid in financing cash flow, so the figure is not always comparable.
  • Cash: Cash and cash equivalents, without securities unless the company reports them as part of the position.
  • Net Debt: Net debt = financial debt excluding lease liabilities minus cash at the same reporting date; the company's own net position may differ.
  • *: derived, the formula is in the hover
  • ≈: calculated, approximation
  • ~: uncertain; the value stays visible, verdicts do not use it
  • °: repaired by a targeted query against the document, or curated with documentary evidence
  • EBIT: EBIT as a fallback: the income statement carries no operating line
  • basic: basic earnings per share as a fallback when diluted is missing
Advertisement

Sources: official investor relations documents#

All original documents used, with type (e.g. quarterly, half-year, annual report), publication date and a direct link to the filing (EDINET/SEC/IR). Every superscript number in the report points to an entry in this list; so every figure can be traced back to its place in the original.

29 documents · 2023 – 2026 · IR
#Document typePublishedLink
#3 / #103IR-Quarter–Open
#6IR-Half–Open
#8 / #108IR-Annual–Open
#10 / #110IR-Quarter–Open
#13IR-Half–Open
#17 / #117IR-Quarter–Open
#20IR-Report–Open
#22IR-Report–Open
#23IR-Report–Open
#29 / #129IR-Quarter–Open
#1 / #101IR-Quarter2023-08-08Open
#7IR-Quarter2023-09-30Open
#2 / #102IR-Quarter2023-11-08Open
#4IR-Annual2024-03-15Open
#5IR-Annual2024-03-27Open
#9 / #109IR-Quarter2024-08-08Open
#11 / #111IR-Quarter2024-11-11Open
#12IR-Annual2025-03-19Open
#15 / #115IR-Annual2025-03-19Open
#14IR-Report2025-03-25Open
#25IR-Report2025-03-31Open
#16 / #116IR-Quarter2025-08-12Open
#24IR-Half2025-08-13Open
#18 / #118IR-Quarter2025-11-11Open
#26IR-Quarter2025-11-12Open
#19IR-Report2026-03-18Open
#21IR-Report2026-03-18Open
#27 / #127IR-Annual2026-03-18Open
#28 / #128IR-Quarter2026-08-11Open

FAQ#

Is there a management forecast (guidance) for FY2026?

Yes. Management has issued targets for FY2026, including Revenue. The guidance tracking chapter shows all targets and checks them against the actuals reported later; neutral, with no estimate of our own.

Which additional key figures does Jenoptik AG report?

As reported for Q2 2026: Order backlog, EBITDA margin, Equity ratio, Cash conversion rate, EBIT margin, Book-to-bill ratio. The chapter Reported KPIs lists every value with its source. Revenue is broken down by Semiconductor & Advanced Manufacturing, Biophotonics, Metrology & Production Solutions, Smart Mobility Solutions.

Does Jenoptik AG pay a dividend?

The filings report on the dividend; most recent entry: dividend per share 0.40² (FY2025) (as reported, no assessment of our own). Details with source links are in the report chapters.

Where can I find the official investor relations documents of Jenoptik AG?

The sources chapter links all 43 original filings used (IR documents) with type, publication date and a direct link; every figure in the report carries a source number.

More reports#

All reports

Advertisement